Skip to content

    Recently Viewed


      A photo of a group from Bridge to Employment

      Bridge to Employment: 25 years of helping young people excel in school—and life

      This Johnson & Johnson program pairs high school kids with local companies and institutes of higher learning to help set them up for success in the work world. We take a look at the inspiring statistics behind that success.

      Share Article
      share to

      Since 1992, Johnson & Johnson’s Bridge to Employment (BTE) program has provided high schoolers with meaningful educational experiences and career prep to help set them up for success as they head off to college.

      In the last 25 years, BTE has come a long way: What started as a U.S.-based program has expanded well beyond its domestic roots to encompass over 80 sites in more than 20 countries, including India, Israel, Mexico, South Africa and Spain.

      Earlier this year, in fact, Johnson & Johnson India was honored with the prestigious Global CSR Leadership Award for Innovation in Corporate Social Responsibility Practices for its work mentoring 50 underprivileged students in Mumbai through the BTE program.

      As the latest class of students graduates from the program on June 21, we’re taking a look at the impact BTE has had over the last quarter-century around the globe.

      Johnson & Johnson’s Bridge to Employment Program

      More from Johnson & Johnson

      Health & wellness
      3D human heart anatomy illustrations

      Do you know what heart failure is? (Hint: It’s probably not what you think)

      For American Heart Month, learn about the advances Johnson & Johnson is making to help turn heart failure into heart recovery for the millions of adults in the U.S. living with the condition, which occurs when the heart muscle isn’t able to pump blood as well as it should.
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.